In vivo brain imaging of tangle burden in humans (Q35050292)

6 August 2017

1 reference

title

In vivo brain imaging of tangle burden in humans (English)

1 reference

6 August 2017

Gary W Small

1 reference

6 August 2017

Eric D Agdeppa

1 reference

6 August 2017

Vladimir Kepe

1 reference

6 August 2017

Nagichettiar Satyamurthy

1 reference

6 August 2017

Sung-Cheng Huang

1 reference

6 August 2017

Jorge R Barrio

1 reference

6 August 2017

publication date

1 December 2002

1 reference

Journal of Molecular Neuroscience

6 August 2017

published in

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

323-327

1 reference

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease

6 August 2017

cites work

1 reference

12 December 2020

Neuropathology of Alzheimer's disease: what is new since A. Alzheimer?

1 reference

12 December 2020

Neuropathological stageing of Alzheimer-related changes

1 reference

12 December 2020

Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe

1 reference

12 December 2020

Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease

1 reference

12 December 2020

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

1 reference

12 December 2020

High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes

1 reference

12 December 2020

Scintigraphy with 123I-serum amyloid P component in Alzheimer disease.

1 reference

12 December 2020

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

1 reference

12 December 2020

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

1 reference

12 December 2020

Quantitation in positron emission computed tomography: 1. Effect of object size

1 reference

12 December 2020

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

1 reference

12 December 2020

Amyloid probes based on Congo Red distinguish between fibrils comprising different peptides

1 reference

12 December 2020

Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies

1 reference

12 December 2020

Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

1 reference

12 December 2020

Development of a monoclonal antibody specific for beta/A4 amyloid in Alzheimer's disease brain for application to in vivo imaging of amyloid angiopathy

1 reference

12 December 2020

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease

1 reference

12 December 2020

Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches

1 reference

12 December 2020

X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation

1 reference

12 December 2020

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

1 reference

12 December 2020

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

12 December 2020

The effects of additional pathology on the cognitive deficit in Alzheimer disease.

1 reference

12 December 2020

Identifiers

DOI

10.1385/JMN:19:3:321

1 reference

Dimensions Publication ID

6 August 2017

1038401407

0 references

1 reference